chrisvoncsefalvay/vaers-outcomes huggingface dataset:
30 minutes after first dose I felt hot/nauseous which lasted a few minutes and went away. The next day had neck pain, nasal congestion, and runny nose. On 1/5/2021 I still had the same symptoms and throat felt like it was swelling and my ears started to hurt. 1/6/2021, had diarrhea. 1/8/2021 was short of breath w/ heart palpitations. 1/11/2021, face swelling on left side, continued having aforementioned symptoms. Eyes started burning and were itchy/dry and watering. 1/15/2021, saw provider and was diagnosed w/ bells palsy and started on steroids
On November 25, 2022, I went in for a complete cardio exam, my doctor ordered an echocardiogram and stress that I was to take the following month. On December 4, 2022, I went in to have both the echocardiogram and stress test. I was given my results 15 days later and found that I had ascending aortic aneurysm. I was advised to keep my weight where it should be for my height, avoid heavy lifting, until I can get in to have the operation to remove the aneurysm.
20 minutes after receiving immunization, patient returned to nurses station stating that she felt warm and had a tingly sensation in her hands. VS were taken, all were within normal limits. Within 7 minutes patient began to complain of chest tightness. VS and lung sounds rechecked all within normal limits. Patient continued to complain of chest tightness. After physician evaluation, epinephrine 0.3mL was given intramuscular route. Patient symptoms improved slowly and were gone within 15 minutes after injection and oral fluids.
maculopapular rash started after January 14th vaccine progressed became widespread after February 11th vaccine.  Itchy uncomfortable but no dyspnea  Fever or mucosal lesions.  Predominantly trunk proximal arms and legs.  No genitalia or mucosal surfaces involved. office visit February 16th.  Oral antihistamines topical steroid cream prescribed.
Given 1st dose Moderna Covid- 19 vaccine on Jan. 11, 2021 in right deltoid- Ususal tiredness, sl. fatigue, headache later that day. That evening, developed swelling in armpit area into right breast area on side near arm.  Used ibuprofen, ice pack for comfort. Next day had body aches, sl. fever, chills. Right arm hurt for 6 days. Armpti swelling reduced by day 4 .On day 4 following vaccine- observed red, swollen, hard area at injection site size of a small saucer. Somwhat blanched white above and below red area.  Went away in two days. Used Ibuprofen, ice for comfort. Symptoms subsided in week.
11/04/2021 Went to emergency room with faciobrachial seizures.
Patient stated 15 hrs after vaccine was given that he was experiencing a migraine and chills.
loss of taste, loss of smell, fever, cough, nasal congestion, sore throat, cough, ear pain. starting on 11/8/21, and increasing /changing on 11/21/21. Was tested 11/12/21 and negative at that time
Patient complaining of flu-like symptoms beginning on day following second vaccination. Exceptional symptoms included severe abdominal pain and hallucinations, lasting 24-48 hours. Little or no fever noted. Did not follow with physician. Self reported to Health Department due to noted abdominal pain and hallucinations.
Two or three hours after receiving the vaccine I had a high fever of 102.8. I experienced dizziness, a terrible headache, stiff neck, my eyes being sensitive to light, abdominal cramps, diarrhea, nausea, joint aches, chills, and all COVID-19 symptoms except loss of taste or smell. I went to the ER on 5/16/2021. The doctor said it was a side effect of the vaccine and said it wasn't meningitis. I was prescribed Ibuprofen, an anti-inflammatory medication, and a muscle relaxant. I am still very lightheaded. I still get joint pain and headaches almost every day. I still have eye sensitivity to light.
This is a spontaneous case, initially received from other health professional on 30-Jan-2018, concerning a 57-year-old, adult, female patient. The patient's medical history and concomitant medications were not reported. On an unspecified date, it was reported that FLUCELVAX QUADRIVALENT vaccine which undergone temperature excursion for about 45 minutes and reported lowest as temperature 0.18 degrees C. It was reported that there are four different excursions which are all exceeding 30 minutes range (explicitly coded as incorrect product storage). On 30-Jan-2018, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch  number: 195215 and expiry date: 30-Apr-2018) (explicitly coded as drug administration error). The reporter assessed this case as non-serious.
large swelling mass to injection site with redness, pain and intense itching mass spread down arm the next day with redness and itching
My right arm was sore; Rubbery legs; Sinus drainage; Sore ears; Stuffy nose; Slight stomach ache; Chills; Tiredness / I was tired for about a week afterwards; Sweats; This is a spontaneous report from a contactable consumer (patient). A 43-year-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, Batch/Lot Number: EW0181), via an unspecified route of administration on 24Jun2021 08:15 (age at vaccination was 43 years) as DOSE 2, SINGLE for COVID-19 immunization at Doctor's office/urgent care. The patient's medical history was not reported. The patient had no known allergies. Concomitant medication included levocetirizine dihydrochloride (XYZAL), nicotine  taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 24Jun2021, by early afternoon patient's right arm was sore. At 5:00PM (by evening) the patient experienced rubbery legs, sinus drainage, sore ears, stuffy nose, slight stomachache, chills, tiredness, and sweats. Patient was tired for about a week afterwards. The events were reported as non-serious and patient was not hospitalized. The outcome of the events was recovered on an unspecified date in 2021.
she developed a fever; This is a spontaneous report from a contactable consumer (Patient) via Pfizer Sponsored program.  A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 05Mar2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously took first dose of BNT162B2 on an unspecified date for COVID-19 immunisation. On an unspecified date (after second dose), patient developed a fever. The patient was asking if she can take Tylenol. The outcome of the event fever was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Shortly after receiving vaccine, patient began to experience tachycardia. VSS were taken by the provider at the time and BP was elevated. Patient was monitored for an additional 45 minutes until vital began to stabilize. She reported some lightheadedness upon standing. The option to send her to the ER was offered or to be picked up by her spouse. She elected to go home and she was stable upon discharge.
covid vaccine breakthrough case  All Pfizer dose 1  3/26/21  ER8730 dose 2  4/16/21  EW0164 dose 3  10/1/21  FF2588
This spontaneous report as received from a certified medical assistant (CMA) refers to a patient (unspecified gender and age). Approximately on an unknown date in February 2013 (on an unknown date approximately one year ago), the patient was vaccinated with first dose of GARDASIL INJ 120 Y (dose, route and lot number unspecified). No concomitant therapy reported. At the time of the report, the patient would like to receive a second dose of GARDASIL. No adverse symptoms reported. No product quality complaint involved. No further information provided. The outcome of event was unknown. Follow up information was received on 18-MAR-2014. In January 2013, the patient had one dose of GARDASIL (dose, route and lot number unspecified), then discontinued and, in January 2014, a new dose of GARDASIL was administered (dose, route and lot number unspecified). The patient had no reactions or side effects (no adverse event). Additional information is not expected.
I have a history of high blood pressure and i typically know when it is elevated however suddenly with out warning I felt my all my vtial signs drop and I felt like I was going to faint. I asked for assistance and I requested they check my sugar. My BP was actually elevated it was 150/100, Heart rate 116 sugar 111 pulse ox sat 100%. I experienced a tingling sensation on my bottom right calf. This episode last about 20 minutes. My vitals were retaken and read as BP 138/80, HR 74. I still had a tingling sensation and slight weakness in lower extremities. A little light headed after words. I have not missed a dose of my blood pressure medication my BP has been at its base line 135/80 typically.
This service member contacted the 24 hour vaccine call center to report reproducible flu-like symptoms of nausea, vomiting, low grade fever and diarrhea that occurred 5-6 days after receipt of ANTHRAX vaccine #1 and #2.  Received ANTHRAX, influenza (injectable), and TYPHOID vaccines in preparation for deployment the end of Feb 09 on 16 Dec 08.  Had no immediate significant local reaction and no systemic symptoms.  Approximately 6 days later he developed severe vomiting, diarrhea and joint aches that lasted about 24 hours.  The rest of the family had similar symptoms.  Patient fully recovered.  Service member received ANTHRAX vaccine #2 on 27 or 28 Jan 09 while in the field (according to the new dosing schedule that eliminates the 2nd 2 week dose.)  He reports he was clinically well at the time.  No other vaccinations were given simultaneously.  Six days later he developed severe vomiting (6-7x in 24 hours) and diarrhea (12-13 x in 24 hours) and low grade temp of 100.7.  States he also had a shortness of breath, tightness in the chest and Tachycardia for a few hours.  Went to see his civilian PCP for evaluation.  No labs drawn or medications given.  No one else in the home ill.  Slept 16 hours.  Feeling better within 24 hours.
Patient with history of allergies was referred to the observation area for thirty (30) minutes. At 11:25 am patient states feeling nauseous. Vital signs at the time were: BP 162/98 and HR 108. Patient states not being diagnosed with hypertension and denies taking any medication for that condition. Patient was kept in observation for monitoring by Dr. At follow-up blood pressure continued to rise and patient was transferred to the emergency room.
This spontaneous report as received from a physician via company representative refers to a 13 year old female patient. The patient's pertinent medical history and drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with GARDASIL (20 MCG-40 MCG-40 MCG-20 MCG/0.5 ML 1 standard package vial of 0.5, dose, frequency and route were not provided). Concomitant medications were not reported. It was reported that, on an unknown date, patient received the GARDASIL and she fainted in the office following vaccination. On an unknown date, several months later, after fainting, the patient was diagnosed with lupus. Physician reported that patient's parents thought that lupus was brought on by GARDASIL. On an unknown date, the patient was sent for further testing to university and unspecified provider from the university reported that the lupus was caused by GARDASIL. It was not confirmed if patient was completed the GARDASIL series or not. The patient did seek the medical attention by visiting the office. The outcome of Systemic lupus erythematosus and syncope was unknown. Causality between the events and suspect therapy was unknown. Upon internal review the event Systemic lupus erythematosus was determined to be medically significant. Additional information has been requested.
All symptoms are 4.18.21 - Present  * New onset POTS like symptoms (70+ BPM increase from laying down to standing)  * Unable to walk without inducing further tachycardia (previously could ski with tachycardia)    - Week of 5/10 lowered to 40BPM increase, still cannot lift things or go up stairs. New occasional heart palpatations * New tingling sensations in left fingertips and left foot * Short term memory confusion * Shortness of breath and visual shakiness upon walking
Initial unsolicited report received from consumer on 20-Sep-2018. This case involves a unknown age male patient who was vaccinated with a dose of FLUZONE HIGH DOSE (Batch number, expiration date, dose, route and site of administration was not reported) on an unknown date. The patients medical history and concomitant medications were not reported. It was a case of actual medication error due to extra dose administered (received the vaccine twice last week). It was unknown whether patient experienced any adverse event following vaccination. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 71-year-old female patient who received SHINGRIX for prophylaxis. On 17th July 2018, the patient received the 1st dose of SHINGRIX (intramuscular) 50 µg. On 17th July 2018, immediately after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient stated that, as soon as she received her dose of SHINGRIX, she started experiencing pain in her arm. She stated, the injection supposedly went into her deltoid muscle, but she thought it might have been a little outside of the deltoid. The pain was at the injection site which extends down her arm towards her elbow. The pain was constant and had not improved any at the time of reporting. The reporter did not consent to follow-up.
Received vaccine 9/18/09 at 11:30am At 7pm she reported significant bodyaches on on left side (vaccine was given left deltoid) from neck to knee. 10/10 pain, weakness. Seen 9/22/09 pain persists 7/10 diffucult to turn neck pain to touch over left side of back. Exan WNL with noted pain. TX NSSAIDS
In early February 2023, I had a couple of pimples on my chin and then became lesions with oozing. They did a biopsy and determined it was a fungal infection, blastomycosis. I had a chest X-Ray and found inflammation. They believe I breathed in a spore, and it moved from my chest to my chin. I have been taking antibiotics for a week and it didn't help. The infectious disease doctor gave me itraconazole and it seems to be helping. I have to get blood work every two weeks. The lesions have reduced in size. Also, in early January I tested positive for COVID-19 while we were on a cruise. My symptoms were just a slight runny nose.
Symptoms: severe and intense migraines; neck stiffness and pain; light sensitivity Treatment: steroid injections at the base of the skull to help lessen the migraines and neck stiffness/began taking topomax. The injections were completed by Doctor and the Topomax was prescribed by Doctor. Diagnosis: Doctor diagnosed me with chemically induced meningitis directly related to the Covid vaccination. Dates: From June 20, 2021 to current
At covid-19 vaccine clinic., MD administered pt. a 4 year old the pfizer biontech 5-11 y vaccine.  NO adverse event reported. father is aware that she is 4 year old and an almost 5 year old.  Father is aware that the vaccine is for 5 years and above but interested in the vaccine. father wants to get the second dose.  child's pediatrician
A report has been received from a Health Professional concerning a 60 year old, female subject, who had been receiving QLAIV (intranasal). Concomitant medications included levothyroxine sodium, pantoprazole, lorazepam, clonidine, rosuvastatin, venlafaxine, ramipril and quetiapine. FLUMIST (intranasal) started on an unknown date. It was reported that a pharmacist dispensed the FLUMIST vaccine to the wrong patient population. The patient recovered from the event of off label administration of FLUMIST QLAIV on 28-Oct-2014. The reporter's description of the event(s) was as follows: no medical history. The report was considered to be non-serious. The reporter has considered that the event of off label administration of FLUMIST QLAIV to be unrelated to the suspect drug. The reporter considered that there was no causal relationship between off label administration of FLUMIST QLAIV and QLAIV. As a Medical Advisor, I have considered the causality between the event off label administration of FLUMIST QLAIV with the suspect drug of QLAIV to be No.
Fever, chills, body aches and fatigue starting 7 hours after the shot, and lasting for 24 hours
Fever/ chills  / fatigue/ headache/ muscle and joint pain/ nausea
Received Td booster on 4/19/2004 - does not recall previous vaccination or reactions.  Had significant swelling in posterior aspect left arm over the next several days associated with discoloration of blue/black bruising and pain.  Swelling has persisted along with the pain in the posterior arm but the discoloration has resolved.  Tender to touch over the area of visible swelling, but no erythema or warmth, no induration, no skin breakdown.  She has pain with movement and use of the left arm.
Left upper arm swelling, redness & warmth of the whole upper arm pm after vaccine area approx size of plum. Was much larger per pt. 6/23/11 Slightly swollen, warm decreased redness. Pt continues to ice & using ADVIL for c/o chills - no temp. PNEUMOVAX arm had reaction.
On Wednesday Dec 13th, 2017 patient received PREVNAR 13 at around 6pm. On Monday, patient came to the pharmacy and per pharmacist, her left arm showed red and bumpy, not around the injection site but below the injection about 2 inches wide and 3 to 4 inches long. On Tuesday morning, patient went to see her primary care doctor and was prescribed LEVAQUIN 500mg #10 - 1 tab qd.
Initial report received from a health care professional on 27 September 2010. A 49-year-old male patient, with a history of tremors after doxycycline 10 years ago, no known allergies, no illness at the time of vaccination and took no medications, received on 26 September 2010 a left deltoid injection of FLUZONE No Preservative 2010-2011, lot number U3572DA. About 4 hours after the FLUZONE on 26 September 2010, he developed a temperature of 103 degrees Fahrenheit, nausea, sweats and flu-like symptoms. On 27 September 2010, the patient had a temperature of 101, felt sweaty and face and jaw felt numb. He saw his physician and was given no treatment. On 28 September 2010, his legs were numb, felt like "mind was racing", speech slurred and felt "anxious". The patient reported no fever on 28 September 2010 and 29 September 2010. The outcome was reported as not recovered. Documents held by sender: None.
Came into hospital with right lower leg pain 10/6/2021. Had vaccine 5/3/2021 at pharmacy.
Started to develop a red rash under abdomen fold. Over the last months this has continuous spread to now it covers my body up to my face. It itches and then hurts when I scratch it. I have been to the Dr 3 times over this. My Dr prescribed a lotion, then prednisone and now Allegra. Nothing has worked.
Patient developed pain and swelling of fingers, wrists, knee, right ankle and toes in mid-March of 2000 just before time to take the last lyme shot.
Dose of vaccine was provided subcutaneous route instead of intramuscular route.  Extreme pain, redness, swelling and tenderness at site x 24 hours.
bumps in mouth on first day, face turned read on second day and bumps went away, third day lips became raw and almost wind burned and chapped then fourth and fifth day lips swelled up very large as well as chin and lower face and cheeks. Benadryl, claritin given together as well as epi pen for emergency use.
muscle spasms and tingling in her feet for a month and a half; muscle spasms and tingling in her feet for a month and a half; This is a spontaneous report from a contactable pharmacist. A 43-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Pharmacist stated she was calling to report an adverse event that occurred in a 43-year-old female patient after she received her second dose of the Pfizer BioNTech Covid-19 Vaccine. The patient has been experiencing muscle spasms and tingling in her feet for a month and a half. Pharmacist denies any questions for Pfizer. Pharmacist requested transfer. The clinical outcome of the event was unknown at the time of report. The lot number for BNT162b2 was not provided and will be requested during follow up.
The pt received the Td vaccine on 8/16/06 after sustaining a cat bite to the left hand. She was also treated with a 7 day course of Augmentin. She reports that approx 1 week later she developed numbness in much of her body and limbs. History of multiple sclerosis, diagnosed 10 years ago, that had been in remission. She went to her neurologist, who felt the numbness was a flare up initiated by the TD vaccine, treated with Copaxone.
neck pain; Stiff neck; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain) and MUSCULOSKELETAL STIFFNESS (Stiff neck) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced NECK PAIN (neck pain) and MUSCULOSKELETAL STIFFNESS (Stiff neck). The patient was treated with CYCLOBENZAPRINE at an unspecified dose and frequency; TRAMADOL at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, NECK PAIN (neck pain) and MUSCULOSKELETAL STIFFNESS (Stiff neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Physical therapy regiment.   Reporter did not allow further contact
Got the shot at 12:30PM on Thursday. Started feeling fever, chills, fatigue, muscle and joint pain, and slight headache at 3:10AM. Recorded temperature of 100.7 degrees with an ear thermometer. Took Tylenol, drank 32oz of cold water, put a cold wash cloth on forehead. After an hour my temperature dropped to 98.8. Felt less achy but still warm.
Total two injections.  During time between vaccine injections developed COVID-19 infection subsequently given bamlanivimab infusion.  90 days post infusion given second vaccine injection.  As indicated noticed several petechiae developing on both calves.